Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 14 (4), 750-63

Harnessing Regulatory T Cells for Clinical Use in Transplantation: The End of the Beginning

Affiliations
Review

Harnessing Regulatory T Cells for Clinical Use in Transplantation: The End of the Beginning

S C Juvet et al. Am J Transplant.

Abstract

Owing to the adverse effects of immunosuppression and an inability to prevent chronic rejection, there is a pressing need for alternative strategies to control alloimmunity. In three decades, regulatory T cells (Tregs) have evolved from a hypothetical mediator of adoptively transferred tolerance to a well-defined population that can be expanded ex vivo and returned safely to patients in clinical trials. Herein, we review the historical developments that have permitted these advances and the current status of clinical trials examining Tregs as a cellular therapy in transplantation. We conclude by discussing the critical unanswered questions that face this field in the coming years.

Keywords: Allograft tolerance; cellular therapy; hematopoietic stem cell transplantation; regulatory T cells; solid organ transplantation.

Similar articles

See all similar articles

Cited by 27 PubMed Central articles

See all "Cited by" articles

Publication types

LinkOut - more resources

Feedback